ZNF45 Inhibitors
Chemical inhibitors of ZNF45 can interact with various signaling pathways that influence the function of this zinc finger protein, which is involved in DNA binding and regulation of gene expression. Staurosporine and Gö6976 target protein kinase C (PKC), a group of enzymes essential to a multitude of cellular processes. Inhibition of PKC by these chemicals can lead to reduced phosphorylation events, which may be necessary for the proper function of ZNF45, thereby inhibiting its activity. Similarly, Dasatinib's inhibition of Src family kinases as well as the BCR-ABL tyrosine kinase can disrupt additional signaling pathways upon which ZNF45 depends. The effect of Dasatinib suggests that tyrosine phosphorylation plays a role in modulating the activity of proteins like ZNF45.
Inhibitors that target the mitogen-activated protein kinase (MAPK) pathway, such as PD98059 and SB203580, can also affect ZNF45. PD98059 specifically inhibits MAP kinase kinase (MEK), thereby preventing the activation of the extracellular signal-regulated kinase (ERK) pathway, a pathway that can regulate ZNF45. SB203580, on the other hand, inhibits p38 MAPK, which is involved in responses to stress and cytokines. The inhibition of these kinases by PD98059 and SB203580 can result in a decrease in ZNF45 activity by blocking the signaling pathways that facilitate its regulatory functions. Other chemicals like SP600125 and Y-27632 inhibit the c-Jun N-terminal kinase (JNK) and Rho-associated protein kinase (ROCK), respectively. JNK and ROCK are involved in transcriptional regulation and cytoskeletal organization, which are important for the localization and activity of transcription factors. By inhibiting these kinases, SP600125 and Y-27632 can alter the signaling and structural framework necessary for ZNF45 function. LY294002, an inhibitor of phosphoinositide 3-kinase (PI3K), and Rapamycin, an inhibitor of the mechanistic target of rapamycin (mTOR), disrupt upstream signaling pathways that are likely to affect ZNF45's role in transcriptional regulation. PD168393, which irreversibly inhibits the epidermal growth factor receptor (EGFR) tyrosine kinase, and Palbociclib, a CDK4/6 inhibitor, can also lead to reduced ZNF45 activity by interfering with growth factor signaling and cell cycle regulation, respectively, indicating that ZNF45 may be connected to broader cellular growth and proliferation signals.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits protein kinase C (PKC), which is essential for many signal transduction pathways. Given that ZNF45 is a zinc finger protein potentially involved in DNA binding and transcriptional regulation, inhibition of PKC can disrupt signal transduction processes that regulate the activity of ZNF45, leading to its functional inhibition. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MAP kinase kinase (MEK), a kinase that activates the extracellular signal-regulated kinase (ERK) pathway, which is implicated in the control of cell functions. Inhibition of MEK and subsequent ERK signaling can inhibit ZNF45 activity by disrupting signaling pathways that ZNF45 relies upon for its regulation of gene expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor. PI3K signaling is involved in many cellular processes, including transcription. By inhibiting PI3K, LY294002 can disrupt the downstream signaling required for the functional activity of ZNF45, leading to its inhibition as ZNF45 may require PI3K signaling for proper transcriptional function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is involved in a variety of cellular processes, including transcription. The inhibition of JNK signaling by SP600125 can lead to the inhibition of ZNF45, as JNK signaling may regulate transcription factors or cofactors that are necessary for ZNF45's role in gene expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. The p38 MAPK pathway is involved in inflammatory responses and can modulate transcription factor activity. Inhibition of p38 MAPK by SB203580 can inhibit ZNF45 by interfering with downstream signaling pathways that regulate the activity of transcription factors or cofactors associated with the functional role of ZNF45. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a Rho-associated protein kinase (ROCK) inhibitor. ROCK is implicated in cytoskeletal organization, which can influence transcription factor localization and activity. Inhibition of ROCK may inhibit ZNF45 by altering the cytoskeletal dynamics and cellular architecture that support the functional activity of ZNF45 in the cell. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a Src family kinase and BCR-ABL tyrosine kinase inhibitor. Tyrosine kinases like Src are involved in various signaling pathways that can regulate transcription factor activity. By inhibiting Src family kinases, Dasatinib could inhibit ZNF45 by disrupting the signaling pathways that ZNF45 relies upon for its function in gene regulation. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Gö6976 is an inhibitor of classical protein kinase C (cPKC) isoforms. PKC isoforms are involved in multiple signaling pathways that regulate transcription factor activity. Inhibition of these PKC isoforms by Gö6976 can lead to the functional inhibition of ZNF45, as PKC signaling is often involved in the regulation of transcription factors or cofactors that ZNF45 may associate with. | ||||||
Imatinib mesylate | 220127-57-1 | sc-202180 sc-202180A | 25 mg 100 mg | $45.00 $111.00 | 61 | |
PD168393 is an irreversible inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. EGFR signaling is involved in cell proliferation and differentiation, which includes transcriptional regulation. By inhibiting EGFR, PD168393 can inhibit ZNF45 by disrupting the signaling pathways that are necessary for the functional activity of ZNF45 in gene regulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. mTOR signaling is critical for cell growth and metabolism, affecting transcriptional regulation. Inhibition of mTOR by Rapamycin can lead to the inhibition of ZNF45 by disrupting mTOR-dependent signaling pathways that ZNF45 may utilize for its role in the regulation of gene expression. | ||||||